Cigna Corporation

Cigna Corporation

CI

$295.92

Updated: 03/11/2026, 17:11:32

Market Cap
$78.19B
Sector
Healthcare
Industry
Medical - Healthcare Plans
Country
US

No historical data available

Company Profile

Cigna Group, established in 1792 and headquartered in Bloomfield, Connecticut, provides insurance products and related services across the United States. The company operates through two primary segments. Its Evernorth division offers a comprehensive array of coordinated and specialized health solutions, including pharmacy services, benefits administration, care management and delivery, and advanced intelligence solutions. These offerings cater to a diverse clientele, such as health plans, employers, government entities, and healthcare providers. Meanwhile, the Cigna Healthcare segment delivers an extensive portfolio of products and services, encompassing medical, pharmaceutical, behavioral health, dental, vision, and health advocacy programs for both insured and self-insured customers. This segment also provides Medicare Advantage, Medicare Supplement, and Medicare Part D plans specifically for seniors, in addition to individual health insurance options available on and off public exchanges. Globally, Cigna Healthcare extends international health coverage and benefits to mobile professionals and employees of multinational organizations. Furthermore, the company issues permanent insurance contracts to corporations, designed to cover the lives of specific employees for funding future benefit obligations. Cigna distributes its various offerings through insurance brokers and consultants, direct sales channels to employers, unions, and individuals, and via both private and public exchanges.

USD
NYSE
CEO: Brian C. Evanko
Employees: 66,685
https://www.thecignagroup.com
Asset Summaries
Latest generated summaries for CI

No summaries found.

Detailed business
Evidence-backed facts extracted from the latest official annual filing.
CI-10-k-fy2025.html4.3 MBtext/htmlENFiled 26/02/2026Period ended 31/12/2025

Business monitoring

Reported and calculated KPIs plus operational exposure disclosed in the FY 2025 filing.

Evidence-backed · 38 KPI observations

Revenue

N/A

FY — · Reported

Net income

$6.0B

FY 2025 · Reported

Gross margin

N/A

FY — · Reported

Free cash flow

N/A

FY — · Reported

R&D intensity

N/A

FY — · Reported

Share repurchases

$3.6B

FY 2025 · Reported

Earnings and cash generation
USD billions, directly sourced from inline XBRL; free cash flow is operating cash flow less capex.
Profitability and reinvestment
Margins and R&D as a percentage of revenue.
Top products and services
Products and services mentioned in the filing; a quantitative sales breakdown was not disclosed.

Other offerings mentioned without separate sales

Pharmacy Benefit Services product suite
Cigna Healthcare segment premium pricing cycle
AI and data/analytics capabilities

Area-level product sales are displayed only when the filing reports a product × geography breakdown. Regional totals are not allocated across products by estimation.

Geographic footprint
What the filing identifies, separated by location role so partner manufacturing is not presented as Apple-owned factories.
1 named headquarters
0 manufacturing countries
0 individually named factories

Map layer

Pins show disclosed operations. The heatmap colors the filing’s reported geographies; regional figures shade the region and are not estimates for each country.

No reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosure
Named headquarters Manufacturing partner country

Only locations and quantities explicitly supported by the filing are displayed. A country-level manufacturing percentage or product allocation is shown only when the source discloses it; materiality scores are never presented as production shares.

How the business makes money

Company overview

Global health company; two segments (Evernorth Health Services, Cigna Healthcare); ~67,700 colleagues; >185M customer relationships in >30 markets; ~1.7M provider relationships as of Dec 31, 2025

98%
Source evidence
“our global workforce of approximately 67,700 colleagues strives to fulfill our mission to improve the health and vitality of more than 185 million customer relationships in more than 30 markets and jurisdictions”

Company overview

Global health services company with Evernorth Health Services; AI-augmented care and benefit administration

90%
Source evidence
“uninterrupted point-of-sale electronic retail pharmacy claims processing is a significant operational requirement for our business”

Evernorth Health Services segment

Evernorth Health Services: Pharmacy Benefit Services and Specialty and Care Services operating segments providing independent and coordinated health solutions

98%
Source evidence
“The Evernorth Health Services segment, through our Pharmacy Benefit Services and Specialty and Care Services operating segments, provides independent and coordinated health solutions”

Cigna Healthcare segment

Cigna Healthcare: U.S. Healthcare and International Health operating segments providing comprehensive medical and coordinated solutions

98%
Source evidence
“Cigna Healthcare, the health benefits segment of The Cigna Group, provides comprehensive medical and coordinated solutions to customers and clients served by our U.S. Healthcare and International Health operating segments”

Other Operations and Corporate

Other Operations: run-off/non-strategic businesses; Corporate: unallocated net interest expense, certain litigation, frozen pension plans, charitable contributions, severance, overhead

95%
Source evidence
“Other Operations comprises the remainder of our business operations, which includes certain continuing, run-off and other non-strategic businesses.”

Rebate guarantee structure

Most clients receive the greater of a minimum rebate guarantee or a contractually agreed-upon percentage of rebates; Express Scripts may bear the risk of securing guaranteed rebate value

92%
Source evidence
“We manage our clients' rebate arrangements, with most choosing to receive the greater of a minimum rebate guarantee or a contractually agreed-upon percentage of rebates.”

Pharmacy Benefit Services product suite

Full pharmacy benefits suite: claims adjudication, retail network administration, formulary management, medical drug management, GPO administration, value-based programs, Wholesale Marketplace, rebate-free model, home delivery pharmacy

95%
Source evidence
“We adjudicate drug claims from retail network participants and provide retail pharmacy network administration, benefit design consultation, drug utilization review, drug formulary management and other services.”

Cigna Healthcare segment premium pricing cycle

Cigna Healthcare premiums set one year in advance

90%
Source evidence
“Premiums in the Cigna Healthcare segment are generally set for a one-year period and are priced well in advance of the date on which the contract commences or renews.”

AI and data/analytics capabilities

AI/augmented intelligence, Gen AI governance (EMG, AI COE), predictive analytics/ML, digital health

90%
Source evidence
“We use artificial intelligence ("AI") to support health care transformation by helping to enable the next generation of accessible, effective, affordable and enhanced health care solutions.”

Operations and dependencies

Pharmaceutical manufacturer relationships

Nonexclusive, short-notice-terminable pharma manufacturer contracts provide rebates/discounts; consolidation or loss would be materially adverse

93%
Source evidence
“Our contracts with pharmaceutical manufacturers are typically nonexclusive and terminable on relatively short notice by either party.”

Global workforce statistics

~67,700 employees worldwide (88% US, 97% full-time, 69% women, 40% US ethnic minorities)

95%
Source evidence
“As of the end of 2025, The Cigna Group employed approximately 67,700 employees worldwide, with about 88% of our employees based in the United States.”

Positioning and strategy

Brokers and benefit consultants as distribution dynamics

Knowledgeable consultants seek competing bids; brokers may take over services Cigna provides

88%
Source evidence
“as brokers and benefit consultants seek to enhance their revenue streams, they look to take on services that we typically provide.”

Transparent rebate-free model adoption timeline

Rebate-free model: Cigna Healthcare adopts for fully insured customers beginning 2027; standard for Evernorth pharmacy benefit clients beginning 2028

95%
Source evidence
“Cigna Healthcare will adopt this new model for its fully insured customers beginning in 2027. It will become the standard model available for Evernorth Health Services pharmacy benefit clients beginning in 2028.”

Commitments to Better

Multiyear 'Commitments to Better' initiative with five focus areas: easier access to care, better support, better value, accountability, transparency

93%
Source evidence
“The Cigna Group has established five key areas of focus, and several initial specific actions, to improve the health of its customers and increase the value it provides”

Digital and AI-driven transformation

Digital-first, virtual-led health care with AI-driven personalization and cybersecurity priority

90%
Source evidence
“one that empowers a customer-centric, digital-first, virtual-led vision for health care”

Risks, financing, and outlook

Other non-current liabilities composition

Other non-current liabilities include postretirement/postemployment benefits, reinsurance liabilities, deferred compensation, and derivatives

90%
Source evidence
“obligations associated with other postretirement and postemployment benefit obligations, reinsurance liabilities, supplemental and deferred compensation plans, and derivative financial instruments”

Litigation/regulatory investigations risk flag

Litigation, regulatory audits and investigations flagged as risk

85%
Source evidence
“the outcome of litigation, regulatory audits and investigations”

Medical cost pricing risk

Small differences between predicted and actual medical costs or utilization rates can significantly change financial results

97%
Source evidence
“Relatively small differences between predicted and actual medical costs or utilization rates as a percentage of revenue can result in significant changes in our financial results.”

Cybersecurity and AI risks

Cyberattack, data security, and AI/ML use risks

95%
Source evidence
“our ability to prevent or contain effects of a potential cyberattack or other privacy or data security incident; risks related to our use of artificial intelligence and machine learning”

Health care cost and pricing risks

Margin compression from health care costs, inflation, price competition, claim estimate risk

95%
Source evidence
“our ability to manage health care costs and respond to price competition, inflation and other pressures that could compress our margins or result in premiums that are insufficient to cover the cost of services delivered to our customers”

Pharmaceutical manufacturer and pharmacy network dependence

Dependence on key pharmaceutical manufacturer relationships and pharmacy networks

95%
Source evidence
“our ability to maintain relationships with one or more key pharmaceutical manufacturers or if payments made or discounts provided decline; changes in the pharmacy provider marketplace or pharmacy networks”

Cybersecurity and third-party vendor exposure

Vendors and company targets of cyberattacks; Change Healthcare Feb 2024 ransomware disrupted certain PBM services

95%
Source evidence
“Change Healthcare, a health technology company owned by UnitedHealth Group and a service provider for certain of our pharmacy benefit management services, was the victim of a ransomware attack in February 2024.”

Client contract renewal/renegotiation risk

Express Scripts client contracts generally three-year terms; loss of large clients would adversely affect results

95%
Source evidence
“our Express Scripts client contracts generally have three-year terms and may be subject to periodic renegotiation of pricing terms based on market factors.”

Pharmacy benefit margin compression and rebate-free model

PBM competition compresses margins; announced commitment to rebate-free model

95%
Source evidence
“If we are unable to respond effectively, including through the implementation of a rebate-free model for our pharmacy benefit services clients, these trends could negatively impact our ability to attract or retain clients”

Government regulation exposure

Substantial federal and state regulation (HHS, CMS, IRS, DOL, OPM, DHA, FTC, SEC, state insurance boards)

95%
Source evidence
“Many aspects of our business are directly regulated by federal and state laws and administrative agencies, such as HHS, Centers for Medicare and Medicaid Services ("CMS"), the Internal Revenue Service ("IRS")”

Financial and indebtedness risks

Ratings downgrade, significant indebtedness, reinsurer credit risk, transaction/impairment risk

95%
Source evidence
“risks related to a downgrade in financial strength ratings of our insurance subsidiaries; the impact of our significant indebtedness and the potential for further indebtedness in the future; credit risk related to our reinsurers”

IT systems dependence

Highly dependent on information systems, third-party systems and cloud providers

93%
Source evidence
“including through unavailability or cyberattack of our information technology systems or those of third parties (including cloud service providers), could cause slower response times, decreased levels of service satisfaction and harm to our reputation.”

Drug pricing benchmark risk

Reliance on third-party drug pricing benchmarks; IRA grants CMS power to negotiate Part D and Part B drug prices

93%
Source evidence
“laws such as the Inflation Reduction Act have granted CMS the ability to negotiate drug prices for high-cost Medicare Part D and Part B drugs”

AI/ML regulatory and legal risk

Generative AI use poses reputational, legal and regulatory risks including hallucination and bias

92%
Source evidence
“generative AI has been known to produce false or “hallucinatory” inferences or output.”

Government program reimbursement risk

Government program concerns may cause decreasing reimbursement rates, payment delays, rate-change restrictions

90%
Source evidence
“Fiscal or other concerns related to the government-sponsored programs in which we participate may cause decreasing reimbursement rates, delays in premium payments, restrictions on implementing changes in premium rates or insufficient increases in reimbursement rates.”

Third-party and multinational operations risk

Third-party/supplier disruption risk; multinational geopolitical and currency risks

90%
Source evidence
“risk of significant disruption within our operations or among key suppliers or third parties; political, legal, operational, regulatory, economic and other risks that could affect our multinational operations, including currency exchange rates”

Rebate guarantee risk

Express Scripts may take on the risk of securing rebate value necessary to meet client guarantees; actual value secured depends on rebate negotiations

90%
Source evidence
“In some rebate arrangements, Express Scripts takes on the risk of securing the rebate value necessary to meet the value guaranteed to its client.”

Industry competition and structural shifts

Competition from consolidation, new entrants, telehealth/AI, biosimilar dynamics, distribution changes

90%
Source evidence
“technological changes and rapid shifts in the use of technology, such as telehealth and AI”

Reputation and public debate exposure

Reputation vulnerable to public debates over health care affordability, accessibility and transparency

87%
Source evidence
“the ongoing public debates over the affordability, accessibility and transparency of health care”

Individual family plans (IFP) exchange exposure

IFP exchange participation in certain states carries mix/volume uncertainty

85%
Source evidence
“Our participation in health insurance exchanges through our IFP offerings in certain states involves uncertainties associated with mix and volume of business”

Material exposure graph

Federal and state health care regulation
Regulatory Exposure

Substantial level of government regulation over the business; new or changed laws can materially affect operations.

Relevance 95·Dependency 90·Confidence 95
Source evidence
“the substantial level of government regulation over our business and the potential effects of new laws or regulations or changes in existing laws or regulations”
Pharmacy Benefit Services
Revenue Exposure

Pharmacy Benefit Services is one of two operating segments of Evernorth Health Services, a core revenue-generating business line.

Relevance 90·Dependency 85·Confidence 95
Source evidence
“Evernorth Health Services includes our Pharmacy Benefit Services and Specialty and Care Services operating segments”
Cigna Healthcare
Revenue Exposure

Cigna Healthcare is the health benefits segment providing medical solutions via U.S. Healthcare and International Health operating segments.

Relevance 90·Dependency 85·Confidence 95
Source evidence
“Cigna Healthcare, the health benefits segment of The Cigna Group, provides comprehensive medical and coordinated solutions”
Pharmacy claims processing platform
Technology Dependency

Uninterrupted point-of-sale electronic retail pharmacy claims processing is a significant operational requirement; platform adjudicates over two billion prescriptions annually.

Relevance 90·Dependency 85·Confidence 90
Source evidence
“uninterrupted point-of-sale electronic retail pharmacy claims processing is a significant operational requirement for our business”
Key pharmaceutical manufacturers
Supplier Dependency

Business depends on relationships with key pharmaceutical manufacturers and payments/discounts they provide; declines could hurt results.

Relevance 90·Dependency 85·Confidence 90
Source evidence
“our ability to maintain relationships with one or more key pharmaceutical manufacturers or if payments made or discounts provided decline”
Pharmaceutical manufacturers
Supplier Dependency

Pharma manufacturers supply rebates, discounts and specialty distribution access; loss or decline of payments would adversely affect results.

Relevance 88·Dependency 80·Confidence 90
Source evidence
“If we lose our relationship with one or more key pharmaceutical manufacturers, or if the payments made or discounts provided by pharmaceutical manufacturers decline, our business and results of operations could be adversely affected.”
Specialty and Care Services
Revenue Exposure

Specialty and Care Services is the second Evernorth operating segment, providing coordinated health solutions.

Relevance 85·Dependency 80·Confidence 92
Source evidence
“through our Pharmacy Benefit Services and Specialty and Care Services operating segments”
Pharmacy provider networks
Supplier Dependency

Changes in the pharmacy provider marketplace or pharmacy networks pose operational and financial risk.

Relevance 85·Dependency 80·Confidence 90
Source evidence
“changes in the pharmacy provider marketplace or pharmacy networks”
Large employer clients
Revenue Exposure

Large clients can easily move between competitors; termination or renegotiation of large client contracts would adversely affect results.

Relevance 85·Dependency 75·Confidence 90
Source evidence
“If one or more of our large clients terminates or does not renew a contract for any reason, or if the provisions of a contract with a large client are modified with terms less favorable to us, our results of operations could be adversely affected”
Inflation Reduction Act
Regulatory Exposure

IRA grants CMS power to negotiate high-cost Medicare drug prices, affecting drug pricing strategy and which medications are prioritized.

Relevance 82·Dependency 55·Confidence 92
Source evidence
“laws such as the Inflation Reduction Act have granted CMS the ability to negotiate drug prices for high-cost Medicare Part D and Part B drugs”
Pharmaceutical manufacturer rebates
Supplier Dependency

Rebate value guaranteed to clients depends on negotiations with pharmaceutical manufacturers; Express Scripts may bear rebate-value risk.

Relevance 80·Dependency 75·Confidence 90
Source evidence
“The actual amount of value secured by Express Scripts is dependent upon the result of its negotiations for rebates.”
Inflationary and interest rate pressures
Cost Driver

Inflation and interest rate pressures could compress margins or make premiums insufficient to cover cost of services.

Relevance 80·Dependency 70·Confidence 90
Source evidence
“inflation and other pressures that could compress our margins or result in premiums that are insufficient to cover the cost of services delivered to our customers”
Artificial intelligence / machine learning
Technology Dependency

AI/ML supports product development and health care transformation but introduces risks; governed by EMG and Responsible AI Principles.

Relevance 80·Dependency 70·Confidence 85
Source evidence
“We use artificial intelligence ("AI") to support health care transformation by helping to enable the next generation of accessible, effective, affordable and enhanced health care solutions.”
Change Healthcare (UnitedHealth Group)
Supplier Dependency

Change Healthcare is a service provider for certain PBM services; its February 2024 ransomware attack caused limited service disruption.

Relevance 78·Dependency 65·Confidence 93
Source evidence
“a service provider for certain of our pharmacy benefit management services, was the victim of a ransomware attack in February 2024. This resulted in limited disruption of certain of our services”
Retail pharmacy network
Supplier Dependency

Company contracts with retail pharmacies across the US to dispense prescriptions and negotiates price discounts for network options.

Relevance 75·Dependency 70·Confidence 90
Source evidence
“We contract with retail pharmacies to provide prescription drugs to customers of the pharmacy benefit plans our clients offer.”
Health services competitors
Competitive Exposure

Ability to compete effectively, differentiate products/services and adapt to a rapidly evolving industry is a key uncertainty.

Relevance 75·Dependency 65·Confidence 85
Source evidence
“our ability to compete effectively, differentiate our products and services from those of our competitors and adapt to changes in an evolving and rapidly changing industry”
Pharmacy rebate regulation
Competitive Exposure

Legislative reforms and regulatory actions related to rebates, reporting, and owned pharmacies may impair ability to price pharmacy products and services appropriately.

Relevance 75·Dependency 60·Confidence 85
Source evidence
“legislative reforms and regulatory or executive actions related to rebates, reporting, owned pharmacies and other activities may adversely affect our ability to price our pharmacy products and services appropriately”
Inflation
Cost Driver

Health care costs affected by external events including inflation, pandemics, natural disasters, and changes in utilization patterns.

Relevance 72·Dependency 50·Confidence 88
Source evidence
“provider billing practices, inflation and changes in customers' health care utilization patterns, pandemics, natural disasters, and other large-scale medical emergencies.”
Economic downturn / employment metrics
Revenue Exposure

Recession or economic downturn could affect employment metrics, which drive insured membership and revenue.

Relevance 70·Dependency 60·Confidence 85
Source evidence
“unfavorable economic and market conditions, the risk of a recession or other economic downturn and resulting impact on employment metrics, stock market or changes in interest rates”
Integrated pharmacy benefit clients
Demand Driver

Rebate economics and client relationships drive pharmacy benefit services revenue; most clients choose rebate guarantees.

Relevance 70·Dependency 60·Confidence 85
Source evidence
“with most choosing to receive the greater of a minimum rebate guarantee or a contractually agreed-upon percentage of rebates”
Artificial intelligence / machine learning
Technology Dependency

AI/ML use creates regulatory and legal challenges including generative AI hallucination and bias risks; cyber threats also enhanced by AI.

Relevance 70·Dependency 55·Confidence 88
Source evidence
“Our use of AI and ML technologies, as well as more recent technological advances in AI/ML, pose risks to us and subject us to new and existing laws and regulations.”
Healthcare affordability and transparency pressure
Demand Driver

Company strategy centers on affordability and transparency, including a rebate-free model adoption timeline, reflecting industry pressure.

Relevance 70·Dependency 50·Confidence 75
Source evidence
“Evernorth Health Services has announced a transformative new pharmacy benefits model to make discounts negotiated with drug companies available upfront to customers buying their medications”
taxation
Tax Exposure

Potential $1.2 billion future tax payments if uncertain tax positions are not sustained, though adequately reserved.

Relevance 70·Dependency 50·Confidence 93
Source evidence
“it could result in future tax payments of approximately $1.2 billion. We are adequately reserved for such positions.”
Brokers and benefit consultants
Customer Exposure

Brokers and consultants influence client decisions and may take on services Cigna typically provides, threatening revenue.

Relevance 65·Dependency 55·Confidence 87
Source evidence
“as brokers and benefit consultants seek to enhance their revenue streams, they look to take on services that we typically provide.”
interest rates
Currency Exposure

Rising cost of capital could adversely affect goodwill and intangible impairment evaluations given $44.9B goodwill balance.

Relevance 55·Dependency 45·Confidence 85
Source evidence
“If we consistently do not achieve our earnings and cash flow projections or our cost of capital rises significantly, the assumptions and estimates underlying the goodwill and intangible asset impairment evaluations could be adversely affected and result in future impairment charges”
Full company information
Latest profile, trading, valuation, and identifier data stored for CI.
Share price
$295.92
Market cap
$78.19B
Exchange
NYSE
Currency
USD
CEO
Brian C. Evanko
Employees
66,685
IPO date
31/03/1982
Beta
0.298
Last dividend
$0.00
Day range
$293.33 – $296.12
52-week range
$255.53 – $316.27
1-day performance
0.25%
1-year performance
15.81%
Current drawdown (1Y)
-6.43%
CIK
0001739940
CUSIP
125523100
ISIN
US1255231003
Created
07/12/2025, 03:18:54
Last update
03/11/2026, 17:11:32

Track Cigna Corporation with an AI analyst

See which prediction-market events move CI, how its filings map to real-world exposure, and what 12 AI strategies are doing with positions like it.

Free forever to follow AlphaBrain’s AI strategies. No card required.

Latest Database News
News linked to CI from your Railway `news_articles` table.